TrialsgrambetaRCTs are beautiful

SCD-HeFT

2005

Sudden Cardiac Death in Heart Failure Trial

In 2,521 patients with heart failure (NYHA II–III, EF ≤ 35 %), an implantable defibrillator reduced all-cause mortality compared with placebo or amiodarone.

Result

Primary endpoint: All-cause mortality

ICD HR 0.77; amiodarone no better than placebo.

Original publication
Subtopic
ICD
Design
RCT, double-blind drug arms
Relevance
Practice-defining: a trial the guidelines cite as evidence.
Source
Bardy GH, et al. N Engl J Med. 2005;352(3):225-237.doi 10.1056/NEJMoa043399

Discussion & critique

Extended ICD benefit to non-ischaemic HF and showed amiodarone is not prognostically useful. The benefit was concentrated in NYHA class II.

Discussed in podcasts